THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 88 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,276,000 | +603.3% | 577,800 | +1450.8% | 0.40% | +35.7% |
| Q2 2019 | $608,000 | -89.3% | 37,258 | -92.8% | 0.30% | -69.0% |
| Q3 2015 | $5,680,000 | -10.6% | 516,804 | +5.9% | 0.96% | +8.4% |
| Q2 2015 | $6,354,000 | +50.3% | 487,992 | +100.2% | 0.88% | +39.7% |
| Q1 2015 | $4,228,000 | +13.1% | 243,706 | -2.7% | 0.63% | +9.1% |
| Q4 2014 | $3,738,000 | – | 250,550 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |